,i  #aafth ,,congress  #ast ,session    
,h4 ,r4 #cehd  ,,in ,,the ,,house ,,of  
,,representatives  ,june #bg1 #bjai,mr4 
,peters 7for himself1 ,mr4 ,pascrell1   
,mr4 ,hudson1 ,mr4 ,holding1 and ,mr4   
,schrader7 introduced the following     
bill2 which was referred to the         
,committee on ,energy and ,commerce1 and
 in addition to the ,committee on ,ways 
and ,means1 for a period to be          
subsequently determined by the ,speaker1
 in each case for consideration of such 
provisions as fall within the           
jurisdiction of the committee concerned 
,a ,,bill  ,to amend title ,,xviii of   
the ,social ,security ,act to provide   
for certain amendments relating to      
reporting requirements with respect to  
clinical diagnostic laboratory tests1   
and for other purposes4  #a4 ,short     
title ,this ,act may be cited as the    
,laboratory ,access for ,beneficiaries  
,act or the ,,lab ,act4  #b4 ,amendments
 relating to reporting requirements with
 respect to clinical diagnostic         

laboratory tests  7a7 ,revised reporting
 period for reporting of private sector 
payment rates for establishment of      
,medicare payment rates ,section        
#ahcd;,a7a7 of the ,social ,security    
,act 7#db ,u4,s4,c4 #aciem-#a7;a77 is   
amended--  7#a7 in paragraph 7#a7-- 7,a7
 by striking ,beginning ,january #a1    
#bjaf and inserting the following3  7,a7
 ,general reporting requirements        
,subject to subparagraph 7,b71 beginning
 ,january #a1 #bjaf  2 and  7,b7 by     
adding at the end the following3  7,b7  
,revised reporting period ,in the case  
of reporting with respect to clinical   
diagnostic laboratory tests that are not
 advanced diagnostic laboratory tests1  
the ,secretary shall revise the         
reporting period under subparagraph 7,a7
 such that--  7i7 no reporting is       
required during the period beginning    
,january #a1 #bjbj1 and ending ,january 
#a1 #bjba2  7ii7 reporting is required  
during the period beginning ,january #a1
 #bjba1 and ending ,march #ca1 #bjba2   

and  7iii7 reporting is required every  
three years after the period described  
in clause 7ii74  2 and  7#b7 in         
paragraph 7#d7--  7,a7 by striking ,in  
this section and inserting the          
following3  7,a7 ,in general ,subject to
 subparagraph 7,b71 in this section  2  
and  7,b7 by adding at the end the      
following3  7,b7 ,exception ,in the case
 of reporting during the period         
described in paragraph 7#a77;,b77ii7    
with respect to clinical diagnostic     
laboratory tests that are not advanced  
diagnostic laboratory tests1 the term   
data collection period means the period 
beginning ,january #a1 #bjai1 and ending
 ,june #cj1 #bjai4  4  7b7 ,corrections 
relating to phase-,in of reductions from
 private payor rate implementation      
,section #ahcd;,a7b77#c7 of the ,social 
,security ,act 7#db ,u4,s4,c4           
#aciem-#a7;b77#c77 is amended-- 7#a7 in 
subparagraph 7,a71 by striking through  
#bjbb and inserting through #bjbc2 and  
7#b7 in subparagraph 7,b7-- 7,a7 in     

clause 7i71 by striking through #bjai   
and inserting through #bjbj2 and  7,b7  
in clause 7ii71 by striking #bjbj       
through #bjbb and inserting #bjba       
through #bjbc4  #c4 ,study and report by
 ,national ,academy of ,medicine  7a7   
,in general ,not later than #ij days    
after the date of the enactment of this 
,act1 the ,administrator of the ,centers
 for ,medicare  ,medicaid ,services     
7referred to in this section as the     
,administrator7 shall enter into an     
agreement with the ,national ,academies 
of ,sciences1 ,engineering1 and         
,medicine 7referred to in this section  
as the ,national ,academies7 to conduct 
a study to review the methodology the   
,administrator has implemented for the  
private payor rate-based clinical       
laboratory fee schedule under the       
,medicare program under title ,,xviii of
 the ,social ,security ,act 7#db        
,u4,s4,c4 #acie et seq474  7b7 ,scope of
 study ,in carrying out the study       
described in subsection 7a71 the        

,national ,academies shall consider the 
following3  7#a7 ,how best to implement 
the least burdensome data collection    
process required under section          
#ahcd;,a7a77#a7 of such ,act 7#db       
,u4,s4,c4 #aciem-#a7;a77#a77 that       
would--  7,a7 result in a representative
 and statistically valid data sample of 
private market rates from all laboratory
 market segments1 including hospital    
outreach laboratories1 physician office 
laboratories1 and independent           
laboratories2 and  7,b7 consider the    
variability of market segments by       
laboratory procedure code4  7#b7        
,appropriate statistical methods for    
estimating rates that are representative
 of the market4  7c7 ,report to         
,congress ,not later than the date that 
is #ah months after the ,administrator  
enters into the agreement described in  
subsection 7a7 with the ,national       
,academies1 the ,national ,academies    
shall submit to the ,administrator1 the 
,committee on ,finance of the ,senate1  

and the ,committees on ,ways and ,means 
and ,energy and ,commerce of the ,house 
of ,representatives a report that       
includes--  7#a7 conclusions about the  
methodology described in such           
subsection2 and  7#b7 recommendations on
 ways to improve such methodology4